Moreover, there is some evidence that genetic variants in the IL-6 inflammatory pathway may be associated with life-threatening disease [6] supporting the therapeutic strategy of IL-6 inhibition in severe COVID-19 cases. This evidence concerns the gene IL6 and COVID-19.